These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13102361)

  • 1. Inactivated influenza virus vaccine in the therapy of herpes zoster; clinical evaluation.
    GRISWOLD CM; BOWEN SS
    Tex State J Med; 1953 Sep; 49(9):693-5. PubMed ID: 13102361
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Levin MJ; Buchwald UK; Gardner J; Martin J; Stek JE; Brown E; Popmihajlov Z
    Vaccine; 2018 Jan; 36(1):179-185. PubMed ID: 28830693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis and treatment of alpha herpesvirus infection--vaccine].
    Kimura H
    Nihon Rinsho; 2000 Apr; 58(4):928-32. PubMed ID: 10774218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes Zoster and herpes simplex management with influenza virus vaccine.
    Brown AM
    J Med Assoc State Ala; 1977 Feb; 46(8):31-4. PubMed ID: 836475
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes zoster in childhood.
    Leung AK; Robson WL; Leong AG
    J Pediatr Health Care; 2006; 20(5):300-3. PubMed ID: 16962434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on influenza virus. IV. Studies on the influenza virus vaccine immunization experiment of man with influenza virus vaccine inactivated with sodium ethylmercurithiosalicylate.
    NAGAKI D; HAGA T; IWASAKI K; NAKASE Y; UCHIYAMA T
    Kitasato Arch Exp Med; 1954 Jun; 27(1-2):1-7. PubMed ID: 13296317
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of herpes zoster with H-influenza vaccine, a preliminary report.
    Brown AM
    J Med Assoc State Ala; 1974 Jun; 43(12):742-4. PubMed ID: 4847301
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.
    Opstelten W; van Essen GA; Hak E
    Vaccine; 2009 Jan; 27(2):192-6. PubMed ID: 18996427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.
    Shen AK; Warnock R; Chu S; Kelman JA
    Vaccine; 2018 Jul; 36(30):4399-4403. PubMed ID: 29909132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
    Afonina NM; Mikheeva IV
    Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster in a 2-year-old vaccinated against varicella.
    Ulman CA; Trevino JJ; Gandhi RK
    Dermatol Online J; 2014 Jan; 20(1):21259. PubMed ID: 24456962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of the effectiveness of inactivated chromatographic influenza vaccine prepared from the native and recombinant strains of influenza virus].
    Rozaeva NR; Bichurina MA; Fridman EA
    Vopr Virusol; 1989; 34(6):738-41. PubMed ID: 2633468
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.
    Glathe H; Lange W
    Drugs Aging; 1995 May; 6(5):368-87. PubMed ID: 7647426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Arnoux S; Weinberger C; Gessner BD
    Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis.
    Baker DW; Brown T; Lee JY; Ozanich A; Liss DT; Sandler DS; Ruderman EM
    J Rheumatol; 2016 Jun; 43(6):1030-7. PubMed ID: 27084914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.